Sientra to Report 4Q19 Financial Results on March 11, 2020
February 26 2020 - 4:05PM
Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company,
announced today that it will release 4Q19 financial results after
the close of trading on Wednesday, March 11, 2020. Sientra will
host a conference call to discuss financial results the same day at
5:00 p.m. Eastern Time.
The dial-in numbers are 844-464-3933 for
domestic callers and 765-507-2612 for international callers. The
conference ID is 9744698.
A live webcast of the conference call will be
available on the Investor Relations section of the Company's
website at www.sientra.com. The webcast will be archived on the
website following completion of the call.
About Sientra
Headquartered in Santa Barbara, California,
Sientra is a diversified global medical aesthetics company and a
leading partner to aesthetic physicians. The Company offers a suite
of products designed to make a difference in patients' lives by
enhancing their body image, growing their self-esteem, and
restoring their confidence. Sientra has developed a broad portfolio
of products with technologically differentiated characteristics,
supported by independent laboratory testing and strong clinical
trial outcomes. The Company’s Breast Products Segment
includes its OPUS™ breast implants, the first fifth generation
breast implants approved by the FDA for sale in the United States,
its ground-breaking Allox2® breast tissue expander with patented
dual-port and integral drain technology, and BIOCORNEUM® the
#1 performing, preferred and recommended scar gel of plastic
surgeons(*). The Company’s miraDry Segment comprises its
miraDry® system, which is approved for sale in over 40
international markets, and is the only non-invasive FDA-cleared
device for the permanent reduction of underarm sweat, odor and hair
of all colors.____________________(*) Data on file
Investor Relations
805-679-8885
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Sep 2023 to Sep 2024